Merck & Co., Inc.MRK
Price as of · delayed, not real-time
A global pharmaceutical company focused on prescription medicines, vaccines, and biologic therapies, Merck generates a significant share of revenue from its oncology franchise, led by blockbuster immunotherapy Keytruda. The company also maintains a sizable vaccines business and an expanding pipeline in oncology, infectious diseases, and cardiometabolic conditions. Investors monitor patent expiration timelines, clinical trial outcomes, and capital allocation as key drivers of long-term earnings growth.
Congressional Interest in Merck & Co., Inc. (MRK)
15 members of Congress have disclosed 577 trades in Merck & Co., Inc. (MRK), a Healthcare company. The buy/sell breakdown shows 21 purchases versus 29 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading MRK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-08-24 | Rohit Khanna | buy | $1K-$15K |
| 2026-08-03 | Rohit Khanna | sell | $1K-$15K |
| 2026-07-08 | Rohit Khanna | buy | $1K-$15K |
| 2026-06-16 | Rohit Khanna | sell | $15K-$50K |
| 2026-06-02 | Rohit Khanna | buy | $1K-$15K |
| 2026-05-15 | Rohit Khanna | sell | $1K-$15K |
| 2026-04-18 | JANE HARMAN | sell | $1K-$15K |
| 2026-03-27 | Alan Armstrong | sell | $15K-$50K |
| 2026-03-10 | Rohit Khanna | sell | $1K-$15K |
| 2026-02-04 | Josh Gottheimer | buy | $1K-$15K |
| 2026-01-29 | Rohit Khanna | sell | $1K-$15K |
| 2026-01-13 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2025-12-19 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-12-18 | Julie Johnson | sell | $1K-$15K |
| 2025-12-04 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2025-12-04 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2025-12-04 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2025-11-18 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-11-13 | Julie Johnson | sell | $1K-$15K |
| 2025-10-27 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2025-09-25 | Rohit Khanna | buy | $1K-$15K |
| 2025-09-23 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2025-09-23 | Valerie Hoyle | sell | $1K-$15K |
| 2025-08-28 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-08-22 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2025-08-14 | Julie Johnson | sell | $1K-$15K |
| 2025-08-05 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-08-04 | Lisa McClain | sell | $1K-$15K |
| 2025-07-24 | Rohit Khanna | sell | $1K-$15K |
| 2025-07-11 | Ritchie John Torres | sell | $1K-$15K |
| 2025-06-27 | MICHAEL T. MCCAUL | sell | $100K-$250K |
| 2025-06-24 | Lisa McClain | buy | $1K-$15K |
| 2025-06-23 | Rohit Khanna | buy | $1K-$15K |
| 2025-06-16 | Scott Franklin | sell | $1K-$15K |
| 2025-06-13 | Julie Johnson | buy | $1K-$15K |
| 2025-05-30 | Gilbert Cisneros | sell | $1K-$15K |
| 2025-05-28 | Rohit Khanna | sell | $1K-$15K |
| 2025-05-28 | Rohit Khanna | sell | $1K-$15K |
| 2025-05-15 | Rob Bresnahan | sell | $15K-$50K |
| 2025-05-05 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-04-29 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-04-23 | Rohit Khanna | sell | $1K-$15K |
| 2025-04-21 | Bruce Westerman | sell | $1K-$15K |
| 2025-04-17 | Jefferson Shreve | sell | $15K-$50K |
| 2025-04-15 | Rohit Khanna | sell | $50K-$100K |
| 2025-04-09 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-04-09 | Rohit Khanna | buy | $1K-$15K |
| 2025-04-08 | Rob Bresnahan | buy | $15K-$50K |
| 2025-04-04 | Rohit Khanna | buy | $1K-$15K |
| 2025-04-04 | Rohit Khanna | sell | $1K-$15K |